• Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101 | Morningstar

    Source: Buzz FX / 12 Dec 2024 23:41:20   America/Chicago


    Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101
    Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101
    PR Newswire
    NEW YORK and SUZHOU, China, Dec.
    Read more...
Share on,